Recipharm Kaysersberg company information, Employees & Contact Information

Recipharm and PLG announce strategic partnership to accelerate development projects GlobeNewswire

LGC opens $72M chemical plant; Recipharm partners with NeuroSense Endpoints News

Oxford taps CDMO Recipharm to handle additional manufacturing work in malaria vaccine collab Fierce Pharma

Recipharm and PLG team up to streamline development and approvals The Pharma Letter

Recipharm, PLG Partner to Accelerate Development Projects Contract Pharma

Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products Stevanato Group

Recipharm Manufacturing Today

Expert Interview: Mark Quick, Recipharm CHEManager

Pharma Formulation Development Outsourcing Forecast Report 2025-2033 Featuring SGS, Intertek, Recipharm, Lonza, Charles River Laboratories, Eurofins Scientific, Labcorp, Thermo Fisher Scientific Yahoo Finance

Recipharm bolsters biologics biz with Vibalogics buy BioProcess International

Recipharm Opens Parenteral Development and Sterility Labs in India Genetic Engineering and Biotechnology News

Advancing Development and Manufacturing of Microbiome-Derived Therapeutics (BIO 2024) PharmTech

Recipharm inks collaboration deal with Exela to boost sterile manufacturing services Fierce Pharma

Recipharm divests two manufacturing sites The Pharma Letter

Recipharm, working on Moderna's COVID vaccine, boosts biologics presence with Arranta Bio, Vibalogics buyouts Fierce Pharma

With deal to buy 7 Recipharm plants, private equity firm Blue Wolf plans new CDMO Fierce Pharma

Recipharm unloads a pair of plants in separate deals as part of its streamlining, growth strategy Fierce Pharma

Recipharm bolsters its inhalation and injectables manufacturing with $650M deal for Consort Medical Fierce Pharma

Recipharm steps up to support development of Transpire's inhaled treatments for asthma, COPD Fierce Pharma

Recipharm and Spektus team up to supply oral CNS drugs The Pharma Letter

Recipharm Bolsters Blow-Fill-Seal Capabilities in France CHEManager

Recipharm Divests Sites in France and the UK CHEManager

With $500M in local pledges, Recipharm plans Moroccan factory to help Africa secure 'vaccine sovereignty' Fierce Pharma

Expert Statement: Greg Behar, Recipharm CHEManager

CDMO Recipharm sees strong Q2 growth as expansion pays off Fierce Pharma

Recipharm reverses decision to close plant in Sweden but faces action on another facility in U.K. Fierce Pharma

Recipharm’s $22.3M blow-fill-seal expansion now operational at Kaysersberg, France, plant Fierce Pharma

Sterile Manufacturing Contract Pharma

Recipharm Acquires Vibalogics, Arranta Bio Healthcare Packaging

Sweden's Recipharm closing 2 plants, cutting 225 workers as growth takes financial toll on the CDMO Fierce Pharma

Recipharm to buy Sanofi inhalation contract business and plant in U.K. for $60M Fierce Pharma

EQT Offers to Buy Recipharm of Sweden in $2.1 Billion Deal Bloomberg

Recipharm expands Italy plant Fierce Pharma

EQT makes $2.8 billion bid for drugmaker Recipharm Private Equity Insights

Recipharm to acquire Consort Medical Chemical & Engineering News

Recipharm Equips Three More Facilities for U.S. Serialization Healthcare Packaging

Recipharm Acquires Lusomedicamenta for $140M Genetic Engineering and Biotechnology News

Recipharm inks $205M deal with India’s Kemwell to expand reach Fierce Pharma

Recipharm board backs takeover bid Speciality Chemicals Magazine

Blue Wolf Capital to Create New CDMO Platform Via TT

France: Blue Wolf takes next steps in building CDMO platform Investors in Healthcare

Scale-Up of a Plasmid DNA Purification Process BioProcess International

Recipharm to buy majority stake in Nitin Lifesciences Mint

Swedish firm Recipharm buys Kemwell businesses for Rs 1360 cr Business Standard

Huge employer to shut on New Year’s Eve Kent Online

Recipharm explores ending operations in Ashton-under-Lyne facility Pf Media

Major employer to axe 150 jobs as it prepares to cease trading Kent Online

Swedish firm Recipharm acquires Nitin Lifesciences for Rs 671 crore Business Standard